On Thursday, AbbVie Inc. (NYSE:ABBV) reported second-quarter 2025 sales of $15.42 billion on Thursday, beating the consensus ...

AbbVie (ABBV) recently revealed mixed financial Q2 2025 results with increased sales but a drop in net income and EPS, ...

Big-name bidders, strategic reviews, and PE exits define an active, high-stakes M&A market so far this summer.